Total Payments
$53,347
2024 Payments
$38,188
Companies
5
Transactions
21
Medicare Patients
400
Medicare Billing
$36,194
Payment Breakdown by Category
Research$38,188 (71.6%)
Consulting$12,206 (22.9%)
Travel$2,747 (5.1%)
Food & Beverage$205.16 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38,188 | 4 | 71.6% |
| Consulting Fee | $12,206 | 3 | 22.9% |
| Travel and Lodging | $2,747 | 8 | 5.1% |
| Food and Beverage | $205.16 | 6 | 0.4% |
Payments by Type
Research
$38,188
4 transactions
General
$15,158
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | $38,188 | 4 | $0 (2024) |
| Novo Nordisk Inc | $9,234 | 4 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $5,515 | 11 | $0 (2017) |
| Zealand Pharma A/S | $300.00 | 1 | $0 (2020) |
| Medtronic MiniMed, Inc. | $109.35 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,188 | 4 | RECORDATI_RARE_DISEASES_INC. ($38,188) |
| 2023 | $9,234 | 4 | Novo Nordisk Inc ($9,234) |
| 2020 | $409.35 | 2 | Zealand Pharma A/S ($300.00) |
| 2017 | $5,515 | 11 | Bayer HealthCare Pharmaceuticals Inc. ($5,515) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | RECORDATI_RARE_DISEASES_INC. | PASIREOTIDE (Drug) | — | Cash or cash equivalent | $15,888.30 | Research |
| Study: PAS576 • Category: ENDOCRINE AGENT | ||||||
| 10/29/2024 | RECORDATI_RARE_DISEASES_INC. | PASIREOTIDE (Drug) | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: PAS576 • Category: ENDOCRINE AGENT | ||||||
| 06/24/2024 | RECORDATI_RARE_DISEASES_INC. | PASIREOTIDE (Drug) | — | Cash or cash equivalent | $18,100.00 | Research |
| Study: PAS576 • Category: ENDOCRINE AGENT | ||||||
| 06/24/2024 | RECORDATI_RARE_DISEASES_INC. | PASIREOTIDE (Drug) | — | Cash or cash equivalent | $2,700.00 | Research |
| Study: PAS576 • Category: ENDOCRINE AGENT | ||||||
| 03/27/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $7,406.25 | General |
| 03/27/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $785.02 | General |
| 03/27/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $648.04 | General |
| 03/27/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $395.00 | General |
| 10/09/2020 | Zealand Pharma A/S | Dasiglucagon (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Type I Diabetus | ||||||
| 01/21/2020 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $109.35 | General |
| Category: Durable Pump | ||||||
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Travel and Lodging | In-kind items and services | $449.80 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Travel and Lodging | In-kind items and services | $205.63 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Travel and Lodging | In-kind items and services | $107.90 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Food and Beverage | In-kind items and services | $42.75 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Travel and Lodging | In-kind items and services | $21.35 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Food and Beverage | In-kind items and services | $19.13 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Food and Beverage | In-kind items and services | $16.99 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Food and Beverage | In-kind items and services | $10.74 | General |
| 12/01/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Food and Beverage | In-kind items and services | $6.20 | General |
| 11/30/2017 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Travel and Lodging | In-kind items and services | $134.10 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PAS576 | RECORDATI_RARE_DISEASES_INC. | $38,188 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 87 | 103 | $29,613 | $9,214 |
| 2022 | 5 | 102 | 114 | $29,609 | $8,223 |
| 2021 | 3 | 72 | 90 | $11,014 | $7,781 |
| 2020 | 6 | 139 | 149 | $15,373 | $10,976 |
Total Patients
400
Total Services
456
Medicare Billing
$36,194
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 40 | $11,436 | $3,954 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,140 | $1,786 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $4,436 | $1,577 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $5,340 | $1,561 | 29.2% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 12 | 12 | $1,260 | $335.76 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 50 | $14,500 | $4,566 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $8,092 | $1,989 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,876 | $980.52 | 25.3% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Office | 2022 | 15 | 15 | $1,575 | $369.66 | 23.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 20 | 20 | $1,566 | $317.35 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 49 | $6,795 | $4,534 | 66.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $3,759 | $2,938 | 78.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 18 | 19 | $460.36 | $308.54 | 67.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 50 | $5,756 | $4,055 | 70.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $4,859 | $3,382 | 69.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 21 | 21 | $2,097 | $1,691 | 80.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 11 | $1,602 | $1,002 | 62.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 27 | 28 | $656.40 | $552.54 | 84.2% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Office | 2020 | 11 | 11 | $401.50 | $292.92 | 73.0% |
About Dr. Adrian Vella, M.D
Dr. Adrian Vella, M.D is a General Practice healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104890607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrian Vella, M.D has received a total of $53,347 in payments from pharmaceutical and medical device companies, with $38,188 received in 2024. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "" ($38,188).
As a Medicare-enrolled provider, Vella has provided services to 400 Medicare beneficiaries, totaling 456 services with total Medicare billing of $36,194. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties Diabetes & Metabolism
- Location Rochester, MN
- Active Since 02/14/2006
- Last Updated 08/21/2020
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1104890607
Products in Payments
- PASIREOTIDE (Drug) $38,188
- Non-Covered $5,515
- Dasiglucagon (Device) $300.00
- Minimed 670G System (Device) $109.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Rochester
Sarah Atkinson, Md, MD
General Practice — Payments: $1.4M
General Practice $1.4M
Steven Ytterberg, M.d, M.D
General Practice — Payments: $127,642
General Practice $127,642
Matthew Drake, Md, MD
General Practice — Payments: $38,591
General Practice $38,591
Yogish Kudva, Mbbs, MBBS
General Practice — Payments: $35,396
General Practice $35,396
Michael Jensen, M.d, M.D
General Practice — Payments: $34,497
General Practice $34,497
Dr. Frank Lamar, D.d.s, D.D.S
General Practice — Payments: $34,205
General Practice $34,205